Filter By
Clear all Advanced
I am/have/had
added new label for I am/have/had
more
I am looking for
added new label for I am looking for
more
Advanced Filters
Found 26 clinical trials
Featured trial
Do You Have Osteoporosis?

Do You Have Osteoporosis?

  • 1240 views
  • 25 Mar, 2021
  • 1 location
Cardiovascular Protection Conservative Effects of Esketamine Versus -opioid Receptor Agonists in General Anesthesia

. Transient receptor potential vanilloid 1 (TRPV1), as a nociceptor, promotes the release of calcitonin gene-related peptide (CGRP) and substance P (SP) in the small diameter primary sensory neurons

  • 0 views
  • 26 Mar, 2021
  • 1 location
The Use of Intranasal Calcitonin to Improve Pain and Activity in Elderly Pelvic Ring Injuries

thrombosis, and, in the case of the pelvis, not prevent subsequent deformity. Calcitonin is a polypeptide containing 32 amino acids, and it plays a role in the regulation of bone metabolism as a hormone that

  • 17 views
  • 09 Dec, 2021
  • 1 location
Novel Insight Into Migraine Pathophysiolgy and Galcanezumab Mechanisms of Action

The purpose of this study is to understand better the mechanisms of action of calcitonin gene related peptide (CGRP) targeted monoclonal antibodies in migraine prevention. Specifically, the

calcitonin
emgality 120 mg in 1 ml prefilled syringe
galcanezumab
antidepressants
headache
  • 0 views
  • 24 Jan, 2021
  • 1 location
Galcanezumab for Vestibular Migraine

Vestibular migraine (VM) has been recognized a distinct subtype of migraine that causes dizziness as the predominant symptom. Criteria for diagnosis have been adopted by the Barany Society. Previous epidemiological research from the investigators has shown that VM affects 2.7% of the adult population of the United States. Yet, despite …

  • 0 views
  • 26 Jan, 2021
  • 1 location
Registry for Migraine - Clinical Core

This study aims to investigate the effect of erenumab on efficacy outcomes, tolerability outcomes, and patient-reported outcomes in individuals with migraine. Furthermore, the study aims to identify clinical predictors of erenumab response.

headache
erenumab
  • 0 views
  • 26 Jan, 2021
  • 1 location
Decoding Pain Sensitivity in Migraine With Multimodal Brainstem-based Neurosignature

Migraine is a highly prevalent and disabling neurological disease, which has a tremendous impact on sufferers, healthcare systems, and the economy. According to the 2016 WHO report, migraine is the second leading cause of years lived with disability, greater than all other neurological diseases combined. Yet, the treatment in migraine …

  • 0 views
  • 24 Apr, 2021
  • 1 location
The Effect of Anti-calcitonin Gene-related Peptide (CGRP) Receptor Antibodies on the Headache Inducing Properties of CGRP and Cilostazol in Migraine Patients

A randomized, double-blind, placebo-controlled, parallel study to investigate the effect of erenumab in calcitonin-gene related peptide and cilostazol experimental models of migraine in humans

calcitonin
erenumab
headache
cilostazol
calcitonin gene-related peptide
  • 22 views
  • 26 Jan, 2021
  • 1 location
Hypersensitivity to CGRP as a Predictive Biomarker of Migraine Prevention With Erenumab

To explore the relationship between clinical response to erenumab and response to intravenous infusion of calcitonin gene-related peptide in individuals with migraine.

calcitonin
headache
erenumab
calcitonin gene-related peptide
  • 0 views
  • 26 Jan, 2021
  • 1 location
Human Electrophysiological Model to Quantify the CGRP-related Axon Reflex of Trigeminal Afferents

The proposed project aims at establishing Calcitonin gene-related peptide (CGRP)-Related Axon Reflex of Trigeminal Afferents as a neurophysiological biomarker for migraine.

  • 0 views
  • 22 Mar, 2021
  • 1 location